Hand-out
Press Releases
October 22, 2024
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
Active Ingredient in HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma and SGX302 for the Treatment of Psoriasis


